Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Other Names for Retatrutide: INN, LY3437943 and UK Status Retatrutide, also known by its development code LY3437943, is an investigational triple receptor agonist being studied for obesity and type 2 diabetes
Others who have already undergone bariatric surgery may use medications to strengthen appetite control and overcome late-stage weight plateaus
Its like replacing the batteries in that beeping fire alarm and putting out the smoldering embers for good
Both tirzepatide and retatrutide represent a major shift in how medical weight loss and metabolic health are being approached
14, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, announced today a major update of its GLP-1 Companion program, unveiling new tools and content designed to enhance and optimize GLP-1 wellness journeys
Shen L, Ji H
US$ 24.06
US$ 24.96
US$ 26.47
US$ 22.54
US$ 22.68
US$ 22.21
